About Us Press Releases
  • Home ›   Press Releases

Ambassador Suresh Reddy Meets Deputy Prime Minister for Health Dr. Khaled Abdel Ghaffar

Posted on: September 02, 2025 | Back | Print

 

Embassy of India
Cairo

***

Ambassador Suresh Reddy Meets Deputy Prime Minister for Health Dr. Khaled Abdel Ghaffar

Ambassador Suresh Reddy met Dr. Khaled Abdel Ghaffar, Deputy Prime Minister for Health, on 25 August at the Egyptian Cabinet in Alamein. Building upon the Strategic Partnership signed between Prime Minister Narendra Modi and President Abdel Fattah El-Sisi in June 2023, both sides discussed ongoing cooperation in the Health and Pharmaceuticals sector and agreed to leverage technology to expand access to healthcare services for all.

Dr. Khaled highlighted Egypt’s suitability as a Gateway to Africa for the supply of pharmaceuticals and vaccines, citing its talented young workforce, excellent infrastructure, and investment-friendly environment. Ambassador Reddy agreed that Egypt is well-positioned to receive more investments from Indian companies and expressed readiness to work together to attract Indian investors to Egypt.

Ambassador Reddy noted the ongoing cooperation in technology transfer between Indian and Egyptian vaccine manufacturing companies and welcomed upcoming Indian investments in oncology and medical devices in Egypt.

India is one of the key suppliers of Active Pharmaceutical Ingredients (APIs) to Egypt, strengthening local vaccine production. Globally, India is the largest provider of generic medicines, accounting for ~20% of global exports by volume and producing 60% of global vaccines, with major companies like Serum Institute of India, Biological-E, and Zydus having technology transfer agreements with Egyptian partners. India exported over USD 30 billion worth of pharmaceutical products in FY 2024-25.

India has a robust manufacturing base in the pharmaceutical sector, with the highest number of US FDA-approved plants outside the US. Over 3,000 pharma companies and 10,500 manufacturing units cater to domestic and global markets. India’s large pool of scientists, chemists, and regulatory experts ensures high-quality, affordable drug production.

There is a growing presence of Indian companies in oncology, rare diseases, and biosimilars, which are crucial for growing economies. A strong talent pool of over 500,000 scientists and chemists underpins this sector in India.

Both sides expressed commitment to intensify bilateral cooperation and expand it to strengthen the health and pharmaceutical ecosystem, with a focus on vaccine and pharmaceutical sector localisation in Egypt.

Alamein
25 August 2025